Delivery Order SPE2DB20D9354-SPE2DB24FX7Y8

Award Date 9/13/24
Potential Completion Date 10/4/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,510.63, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract award, valued at $9,952.48, is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which enables the DLA to issue firm fixed-price delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,855.66, is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML medical product. The delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at up to $499,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,847.92 contract covers the supply of EXPAREL 266 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military health facilities worldwide. This delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with...
This is a $29,846.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. The delivery order has an ultimate completion date of September 24, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,427.82 contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which covers a comprehensive range of...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,495.90 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,308.30 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,487.22 delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which allows the...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB24FX7Y8
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,081.15 award is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a medication used for pain management. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group leverages this status to secure direct federal contract awards without set-aside designations, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/13/24, 9:28 AM